The qRT-PCR assay results demonstrated a significant decrease in VANGL2 mRNA expression in the tested glioma cells following transfection with shVANGL2 #1 and shVANGL2 #2, comparing to those transfected with scrambled control shRNA (shControl) (Figure 3A). This evidence concerns the gene VANGL2 and central nervous system cancer.